Latest news

CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference

CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference

Spartan Capital Annual Investor Conference

CEO of eXoZymes to Present at Spartan Capital Securities’ Second Annual Investor Conference

CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference

Podcast: 'The Catalyst' interviews CEO, Michael Heltzen

Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025

World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignore

Inside Biotech podcast interviews CEO, Michael Heltzen

Podcast: 'Inside Biotech' interviews CEO, Michael Heltzen

CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.

Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical Committees

The challenges of SynBio

Transcript: Q2 2025 Earnings Call

eXoZymes provides second quarter 2025 update at 5PM EST today